GROWBLOX SCIENCES (GBLX)

0.2951+0.0151 ( +5.3929% ) Jun25

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

GBLX Detailed Quote

Last Trade: 0.2951
Trade Time: 3:56pm
Change: +0.0151
Perc Change: +5.3929%
Prev Close: 0.2800
Open: 0.2790
Day's Range: 0.2700 - 0.2995
Bid: N/A
EPS -0.1420
52wk Range: 0.2100 - 0.6500
Volume: 271852
Avg Vol: 537758
Market Cap: 32.73M
P/E (ttm): N/A
PES (ttm): -0.1420
Ask: N/A

GBLX Recent Headlines

  • GB Sciences Announced As LSU Bid Winner 06/16/2017 05:42 PMSFO 0000000165 for the cultivation, production and use of medical marijuana. Louisiana State University and Agricultural and Mechanical College (hereinafter referred as the "University" or "LSU") is the state's comprehensive research university. The University is classified by the Carnegie Foundation as a Doctorate-granting university with very high research activity – one of the only 27 public and 23 private universities in the nation. The University's instructional programs include 194 undergraduate and graduate/professional degrees.
  • GB Sciences Builds Broad Cannabis Patent Portfolio -- CFN Media 06/16/2017 01:00 PMCFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview with CEO John Poss, discussing GB Sciences Inc. and its drug ...
  • GB Sciences Files Patent Application for Chronic Pain and Heart Therapies 05/23/2017 10:30 AMLAS VEGAS, May 23, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of its latest patent application by its wholly-owned subsidiary, Growblox Life Sciences, LLC for ...
  • GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman 05/22/2017 10:30 AMLAS VEGAS, May 22, 2017 /PRNewswire/ -- GB Sciences, Inc. (GBLX) is pleased to announce the appointment of Mr. Leslie Bocskor as Vice Chairman, effective April 28, 2017.  John Poss remains Chairman of the Board and CEO. Bocskor has been a director of GB Sciences ("the Company") since May 2016, and in this role has been instrumental in the Company's capital formation process and in the Company's relationship with its investment bank, Network 1.  Network 1 has raised over $14 million to fund GB Sciences' further growth and investments.  Bocskor also brought Shane Terry to the Board of Directors.  Mr. Terry is an independent consultant who provides advisory services to Medical Marijuana Establishments (MME's) in Nevada and other states.  With Bocskor's focus on shareholder value in building a biopharma and life sciences powerhouse with strong IP, innovative research programs, and technology, he brings a broad understanding of the future of cannabis markets, investment banking, and cannabis policy.
  • GB Sciences Celebrates Their First Las Vegas Harvest 05/16/2017 10:30 AMLAS VEGAS, May 16, 2017 /PRNewswire/ -- GB Sciences, Inc. (GBLX) is pleased to announce that initial harvest at its Cultivation Lab facility in Las Vegas, Nevada. When fully operational, Cultivation Lab will house 7,200 cannabis plants under 600 grow lights within its 28,000ft., and is expected to generate approximately $10 million in annual revenue. The beginning of the Company's revenue stream is exciting!  GB is one of only a handful of American public companies that actually produce cannabis, and is one of only two companies that are fully reporting, and therefore are fully transparent to investors.  More importantly is the fact that GB has an innovative plan for the use of those revenues, and the substantial profits that they will create.

FIND OUT HOW MUCH MOMENTUM IS DRIVING YOUR MARIJUANA STOCK!

AS SEEN ON
>>